Home › Islet Cell Adenoma › Pennsylvania › Philadelphia
Islet Cell Adenoma clinical trials in Philadelphia, PA
3 studies for Islet Cell Adenoma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- University of Pennsylvania, Philadelphia
Nutrition Intervention for Pancreatic Cancer
Recruiting
- Children's Hospital of Philadelphia, Philadelphia
- University of Pennsylvania Abramson Cancer Center, Philadelphia
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
RecruitingPhase 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Islet Cell Adenoma trials in other cities
- Rochester, MN5 studies
- Los Angeles, CA5 studies
- Washington, DC4 studies
- Phoenix, AZ4 studies
- Portland, OR4 studies
- St. Louis, MO4 studies
- Chicago, IL4 studies
- Boston, MA3 studies
- Salt Lake City, UT3 studies
- Jacksonville, FL3 studies
- Nashville, TN3 studies
- Lexington, KY3 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.